Literature DB >> 1008959

Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure.

M J Weston, I C Talbot, P J Horoworth, A K Mant, R Capildeo, R Williams.   

Abstract

In a series of 106 patients with fulminant hepatic failure and grade 4 encephalopathy, cardiac arrhythmias and other abnormalities occurred in 92 per cent. The most common was sinus tachycardia (75%) and this was the only abnormality in 22 per cent of the patients. Sudden cardiac arrest occurred in 25 per cent, various ectopic beats in 20 per cent, and heart block or bradycardia in 18 per cent. Other electrocardiographic abnormalities, mostly of the T wave and ST segment, were found in 31 per cent. Cardiac and respiratory arrests were usually unrelated to each other and both frequently occurred without warning. Only 7 out of 71 patients with arrhythmias other than sinus tachycardia survived, compared with 15 out of 31 patients without them (P less than 0-005). During the latter part of the series when an arrhythmia computer was used to monitor 38 patients, it was shown that significantly lower arterial oxygen levels occurred in those with arrhythmias, other than sinus tachycardia, than in those without. They were also found to be more acidotic and hyperkalaemic, and a higher number required dialysis and ventilation. Macroscopical cardiac abnormalities including scattered petechial haemorrhages, small pericardial effusions, and fatty, pale, and flabby ventricles, were found at necropsy in 64 per cent of the patients examined. Combinations of these macroscopical abnormalities occurred, particularly in the paracetamol overdose group. Another necropsy finding of possible significance in the pathogenesis of arrhythmias was cerebral oedema, present in 48 per cent of the patients examined, and often associated with coning of the brain stem. However, 7 of the 16 patients who suffered asystolic cardiac arrests had no macroscopical abnormality of either heart or brain. In the management of patients with fulminant hepatic failure continuous cardiac monitoring is essential. Correction of the biochemical and coagulation defects may decrease the frequency of arrhythmias but studies of the mechanism and control of cerebral oedema and its relation to cardiovascular function are urgently needed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008959      PMCID: PMC483152          DOI: 10.1136/hrt.38.11.1179

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

1.  Bradycardias after tracheal disconnection.

Authors:  S Greer; P Haji-Michael; G R Park
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 2.  Fulminant hepatic failure.

Authors:  R J Yanda
Journal:  West J Med       Date:  1988-11

Review 3.  Adequacy and support of physiological functions in the acutely ill cirrhotic patient.

Authors:  I Giovannini; G Boldrini; C Chiarla; M Castagneto; G Sganga; G Tramutola; F Caracciolo; G Castiglioni
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Toxic myocarditis in paracetamol poisoning.

Authors:  E Fagan; A Forbes; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 5.  Paracetamol.

Authors:  T J Meredith; R Goulding
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

6.  Fulminant hepatic failure and artificial liver support.

Authors:  A E Gimson; R Ede; S Braude; R D Hughes; P J Langley; R Williams
Journal:  Gastroenterol Jpn       Date:  1982-04

7.  Progress in the management of fulminant hepatic failure.

Authors:  S Braude; A E Gimson; R Williams
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

Review 8.  Non-narcotic analgesics. Problems of overdosage.

Authors:  T J Meredith; J A Vale
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Paracetamol cardiotoxicity.

Authors:  A Armour; S D Slater
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

10.  Dysrhythmias following intravenous metoclopramide.

Authors:  D E Withington
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.